History of cannabis and the endocannabinoid system

  title={History of cannabis and the endocannabinoid system
  author={M. A. Crocq},
  journal={Dialogues in Clinical Neuroscience},
  pages={223 - 228}
  • M. Crocq
  • Published 1 September 2020
  • History
  • Dialogues in Clinical Neuroscience
This article retraces the story of cannabis from the earliest contacts of humans with the plant to its subsequent global expansion, its medicinal uses, and the discovery of the endocannabinoid system in the 20th century. Cannabis was attested to around 12 000 years ago near the Altai Mountains in Central Asia, and since then, cannabis seeds have accompanied the migration of nomadic peoples. Records of the medicinal use of cannabis appear before the Common Era in China, Egypt, and Greece… 

Exploration of Multiverse Activities of Endocannabinoids in Biological Systems

The current review highlights the functioning, synthesis, and degradation of endocannabinoid, and explains its functioning in biological systems.

Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review

Examining the negative effects of obesity, and how the use of Δ9-tetrahydrocannibinol (THC) or cannabidiol (CBD) can impact rates of this global pandemic at different timepoints of life found a positive correlation between prenatal cannabis use and obesity rates in the children as they matured.

Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation

The chemical properties and bioavailability of THC and CBD, their main mechanisms of action, and their role in oxidative stress and inflammation are discussed.

Extraction of Bioactive Compounds From Cannabis sativa L. Flowers and/or Leaves Using Deep Eutectic Solvents

The increasing demand for medical cannabis urges the development of new and effective methods for the extraction of phytocannabinoids. Deep eutectic solvents (DESs) are an alternative to the use of

WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications

The process was historically unprecedented, of political relevance to both medical Cannabis and evidence-based scheduling generally, and the landscape resulting from accepted and rejected recommendations allow countries to continue creating decentralised, non-uniform systems for access to and availability of “Cannabis” and “cannabis resin” for medical purposes.

“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained

It is proposed that much is still unknown about adverse reactions to cannabis use, and its integration with medical treatment should be conducted cautiously with consideration of the individual patient, effector cells, microenvironment, and the immune system.

An Optimized Terpene Profile for a New Medical Cannabis Oil

The purpose of this analytical study was to develop an advanced formulation of medical Cannabis oil (MCO) comparing the chemical profile of different extracts obtained with two existing methods

What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

The role of the ECS and the impact of genetic factors on endocannabinoid system modulation in the pathogenesis of obesity is explained and the search for potential new targets for health assessment, treatment, and the development of possible therapies in obesity is emphasized.



Medical Cannabis: A plurimillennial history of an evergreen

Evidence of its use in numerous pathologic conditions especially for its anti‐inflammatory, antiseptic, and anticonvulsing properties that support the requirement to direct the present research efforts into the definitive understanding of its efficacy are reported.

Phytochemical and genetic analyses of ancient cannabis from Central Asia

These investigations provide the oldest documentation of cannabis as a pharmacologically active agent, and contribute to the medical and archaeological record of this pre-Silk Road culture.

Phytocannabinoids beyond the Cannabis plant – do they exist?

This commentary summarizes and critically discusses recent findings on non‐cannabinoid plant constituents reported to bind to and functionally interact with CB receptors in Cannabis sativa L. has a long history as a medicinal plant and was fundamental in the discovery of the endocannabinoid system.

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

It is believed that the therapeutic significance of cannabinoids is masked by the adverse effects and here alternative strategies are discussed to take therapeutic advantage of cannabinoids.

On the Preparations of the Indian Hemp, or gunjah*

An adequate view is presented of what has been recorded of the early history, the popular uses, and employment in medicine of this powerful and valuable substance, and several experiments which were instituted on animals, with the view to ascertain its effects on the healthy system.

Cannabinoid pharmacology: the first 66 years

  • R. Pertwee
  • Biology, Medicine
    British journal of pharmacology
  • 2006
Research into the pharmacology of individual cannabinoids that began in the 1940s is concisely reviewed and it is described how this pharmacological research led to the discovery of cannabinoid CB1 and CB2 receptors and of endogenous ligands for these receptors.